Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation

Journal of Virological Methods

Volumn 139, Issue 1, 2007, Pages 103-105

  Niedrig, M ^a   Sonnenberg, K ^b   Steinhagen, K ^b   Paweska, J T ^c  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Institute of Experimental Immunology   (Germany)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

Diagnostic; ELISA; IFAT; Immunofluorescence; Virus neutralisation; West Nile virus (WNV)

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CROSS REACTION; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SERUM; TICK BORNE ENCEPHALITIS; VIRUS NEUTRALIZATION; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

ANTIBODIES, VIRAL; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTRALIZATION TESTS; WEST NILE VIRUS;

DENGUE VIRUS; FLAVIVIRIDAE; TICK-BORNE ENCEPHALITIS VIRUS; WEST NILE VIRUS; YELLOW FEVER VIRUS;

EID: 33845228420     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.09.009     Document Type: Article

References (9)

1. Barenfanger J., Drake C., Lawhorn J., O'Brien J., and Mueller T. Clinical impact of timely reporting of IgM for West Nile Virus. J. Clin. Virol. 34 2 (2005) 122-124
2. Centers for Disease Control and Prevention (CDC) 2005. West Nile virus activity, United States, January 1-December 1, 2005. MMWR Morb. Mortal Wkly. Rep. 16. 54 (49), 1253-1256.
3. Jupp P.G., Blackburn N.K., Thompson D.L., and Meenehan G.M. Sindbis and West Nile virus infections in the Witwatersrand-Pretoria region. S. Afr. Med. J. 70 (1986) 218-220
4. Koraka P.H., Zeller M., Niedrig A.D.M.E., Osterhaus, and Groen J. Reactivity of serum samples from patients with a Flavivirus infection measured by IFA and ELISA. Microb. Infect. 4 (2003) 1209-1215
5. Levett P.N., Sonnenberg K., Sidaway F., Shead S., Niedrig M., Steinhagen K., Horsman G.B., and Drebot M.A. Use of IgG avidity assays for differentiation of primary from previous infections with West Nile virus. J. Clin. Microbiol. 43 12 (2005) 5873-5875
6. McIntosh B.M., Jupp P.G., Dos Santos I., and Meenehan GM. Epidemics of West Nile and Sinbis viruses in South Africa with Culex (Culex) univittatus Theobald as vector. S. Afr. J. Sci. 72 (1976) 295-300
7. Niedrig M., Lademann M., Emmerich P., and Lafrenz M. Assessment of IgG antibodies directed against Yellow Fever Virus after vaccination with 17D by different assays: neutralisation test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Trop. Med. Int. Health 4 12 (1999) 867-871
8. Niedrig, M., Donoso-Mantke, O., Zeller, H., 2006. External quality assurance study on diagnostic of West Nile serology. J. Clin. Virol. under revision.
9. Swanepoel R., Struthers J.K., Erasmus M.J., Shepherd S.P., and McGillivray G.M. Comparison of techniques for demonstrating antibodies to Rift Valley fever virus. J. Hyg. 97 (1986) 317-329